Akoya Biosciences, Inc. (AKYA)
NASDAQ: AKYA · Real-Time Price · USD
1.270
0.00 (0.00%)
Apr 24, 2025, 4:00 PM EDT - Market closed
Akoya Biosciences Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 |
| Revenue | 81.67 | 96.63 | 74.86 | 54.92 | 42.44 | Upgrade
|
| Revenue Growth (YoY) | -15.48% | 29.09% | 36.31% | 29.39% | 0.49% | Upgrade
|
| Cost of Revenue | 33.79 | 40.33 | 31.47 | 20.7 | 16.54 | Upgrade
|
| Gross Profit | 47.88 | 56.31 | 43.39 | 34.22 | 25.91 | Upgrade
|
| Selling, General & Admin | 69.32 | 87.36 | 79.65 | 51.02 | 23.98 | Upgrade
|
| Research & Development | 19.75 | 24.97 | 23.21 | 15.7 | 9.6 | Upgrade
|
| Operating Expenses | 89.06 | 112.34 | 109.6 | 71.44 | 37.4 | Upgrade
|
| Operating Income | -41.18 | -56.03 | -66.21 | -37.23 | -11.49 | Upgrade
|
| Interest Expense | -10.43 | -8.76 | -4.55 | -3.12 | -2.72 | Upgrade
|
| Interest & Investment Income | 2.51 | 3.49 | 0.78 | 0.09 | - | Upgrade
|
| Other Non Operating Income (Expenses) | -2.23 | -0.35 | -0.86 | -3.23 | -0.26 | Upgrade
|
| EBT Excluding Unusual Items | -51.33 | -61.65 | -70.84 | -43.48 | -14.47 | Upgrade
|
| Merger & Restructuring Charges | -3.09 | - | - | - | - | Upgrade
|
| Gain (Loss) on Sale of Investments | 1.66 | 0.01 | 0.22 | - | - | Upgrade
|
| Asset Writedown | -2.97 | - | - | - | - | Upgrade
|
| Other Unusual Items | 0.51 | -1.64 | 0.1 | 0.4 | -2.19 | Upgrade
|
| Pretax Income | -55.22 | -63.28 | -70.52 | -43.08 | -16.66 | Upgrade
|
| Income Tax Expense | 0.15 | 0.04 | 0.12 | -0.14 | 0.04 | Upgrade
|
| Net Income | -55.37 | -63.32 | -70.64 | -42.94 | -16.71 | Upgrade
|
| Preferred Dividends & Other Adjustments | - | - | - | 1.44 | 5.06 | Upgrade
|
| Net Income to Common | -55.37 | -63.32 | -70.64 | -44.37 | -21.76 | Upgrade
|
| Shares Outstanding (Basic) | 49 | 44 | 38 | 27 | 2 | Upgrade
|
| Shares Outstanding (Diluted) | 49 | 44 | 38 | 27 | 2 | Upgrade
|
| Shares Change (YoY) | 11.22% | 17.72% | 40.34% | 1034.62% | 4.15% | Upgrade
|
| EPS (Basic) | -1.12 | -1.43 | -1.87 | -1.65 | -9.18 | Upgrade
|
| EPS (Diluted) | -1.12 | -1.43 | -1.87 | -1.65 | -9.18 | Upgrade
|
| Free Cash Flow | -46.56 | -54.55 | -60.86 | -41.16 | -10.14 | Upgrade
|
| Free Cash Flow Per Share | -0.94 | -1.23 | -1.61 | -1.53 | -4.28 | Upgrade
|
| Gross Margin | 58.62% | 58.27% | 57.96% | 62.31% | 61.04% | Upgrade
|
| Operating Margin | -50.43% | -57.98% | -88.44% | -67.78% | -27.08% | Upgrade
|
| Profit Margin | -67.79% | -65.53% | -94.36% | -80.79% | -51.27% | Upgrade
|
| Free Cash Flow Margin | -57.01% | -56.45% | -81.29% | -74.95% | -23.89% | Upgrade
|
| EBITDA | -33.53 | -47.14 | -59.06 | -32.43 | -7.68 | Upgrade
|
| EBITDA Margin | -41.05% | -48.78% | -78.89% | -59.06% | -18.09% | Upgrade
|
| D&A For EBITDA | 7.65 | 8.89 | 7.15 | 4.79 | 3.82 | Upgrade
|
| EBIT | -41.18 | -56.03 | -66.21 | -37.23 | -11.49 | Upgrade
|
| EBIT Margin | -50.43% | -57.98% | -88.44% | -67.78% | -27.08% | Upgrade
|
| Revenue as Reported | 81.67 | 96.63 | 74.86 | 54.92 | 42.44 | Upgrade
|
| Advertising Expenses | 1.23 | 2.33 | 4.64 | - | - | Upgrade
|
Updated Mar 17, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.